View in EDS HTML Full Text PDF Full Text

Quantitative bone SPECT/CT-derived tumor burden as a prognostic biomarker in metastatic castration-resistant prostate cancer treated with Ra-223.

Saved in:

Bibliographic Details
Title:	Quantitative bone SPECT/CT-derived tumor burden as a prognostic biomarker in metastatic castration-resistant prostate cancer treated with Ra-223.
Authors:	Fukushima, Yoshimitsu¹ (AUTHOR) fuku@nms.ac.jp, Kimura, Go² (AUTHOR), Akatsuka, Jun² (AUTHOR), Honda, Yoshimitsu¹ (AUTHOR), Nakaoka, Yujiro¹ (AUTHOR), Hayashi, Hiromitsu¹ (AUTHOR), Kumita, Shinichiro¹ (AUTHOR)
Source:	EJNMMI Reports. 7/13/2026, Vol. 10 Issue 1, p1-20. 20p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	3005074X
DOI:	10.1186/s41824-026-00309-4